Aastrom Biosciences Inc., of Ann Arbor, Mich., appointed James Cour president and chief operating officer.
Acambis plc, of Cambridge, UK, appointed David Lawrence chief financial officer.
Aclara BioSciences Inc., of Mountain View, Calif., appointed Roy Herbst to its scientific advisory board.
Adolor Corp., of Exton, Pa., appointed James Barrett chief scientific officer.
Affymax Inc., of Palo Alto, Calif., appointed Lee Douglas to its board.
Allegent Technology Group, of Woodbury, N.Y., appointed Michael Swetnam to its board.
Amnis Corp., of Seattle, Wash., appointed Howard Goldstein senior vice president of sales and marketing.
ViroLogic Inc., of South San Francisco, promoted Michael Bates to vice president of clinical research.
ZymoGenetics Inc., of Seattle, appointed James Harper to its board and named John Calhoun director of corporate communications and investor relations.
Zyvex Corp., of Richardson, Texas, appointed Jonathan Javitt to its scientific advisory board.